In December, we reported on the retraction of a paper in the Proceedings of the National Academy of Sciences on a potential treatment for breast cancer. We later found out that the retracted research was part of the basis of a company that had an initial public offering a few weeks later. How the company dealt with the news of the retraction made for an interesting follow-up, and speaks well of the principles of the principals.
This article has been retracted at the request of the Editors of Physics Letters A because there are unsettled issues on how the research was carried out, how the data were acquired and analyzed. The article was removed from the journal issue before printing although it appeared online. In addition, the article was accidentally published online twice in the same journal.
As the notice suggests, this was actually the second retraction, of the same paper. Here was the first, in 2008, shortly after the paper was published. And here is a removal notice, from later that year. We haven’t come across such an occurrence before, although we’ve been writing Retraction Watch for less than a year.
There are six editors of Physics Letters A, and we tried them all for comment on the “unsettled issues.” A few pointed to Burkhard Fricke, the communicating editor for the paper, who is no longer with the journal. He didn’t respond to requests for more information.
As we reported nearly two weeks ago, the eminent surgeon Lazar Greenfield recently lost his position as editor-in-chief of Surgery News over a Valentine’s Day editorial that some readers, particularly women, found offensive. Surgery News is an in-house publication of the American College of Surgeons (although it’s published by Elsevier), and Greenfield was scheduled to take the gavel in October as the new president of the college.
A team of Australian medical writers who analyzed four decades worth of retractions has reached the conclusion — we trust you’re sitting — that people in their profession are more honest than, well, the rest of us.
According to the authors, articles in the medical literature are substantially less likely than other papers to be retracted for any reason, including mistakes or misconduct, if they have a medical writer as a declared co-author. The same applies for articles produced with the help of drug and device makers, either financial support or authorship assistance, the study found. And when both occur, retractions are vanishingly rare. Indeed, they found no instance of a retraction resulting from misconduct.
Retraction Watch readers will no doubt have realized by now that we are often frustrated by the opacity of many of the retraction notices we cover. And some critics may wonder if we’re overstating that case.
It’s a mind-boggling story: A United Airlines pilot claims to be a cardiologist and was eagerly sought after for medical conferences at which he taught doctors teamwork. He shared millions in grants, according to the Associated Press. But as the AP reports, William Hamman wasn’t a cardiologist at all, having never even finished medical school.
A prominent Stanford University chemistry lab has been forced to retract a paper in the Journal of the American Chemical Society (JACS). According to the retraction notice:
Due to inconsistencies between some of the assigned structures and the experimental data that appear in the paper, the authors retract this publication. We regret very much this unfortunate occurrence.
Human nature being what it is, however, it would seem natural for authors to recommend reviewers who are a bit more likely to recommend acceptance. Such author-suggested reviewers are just one source of the two or three experts who vet a particular paper, and are required to disclose any conflicts of interest that might bias their recommendations.
Still, editors have justifiable concerns that using too many of them may be subtly increasing their acceptance rate. That’s why we’re interested in such issues at Retraction Watch. Increasing a journal’s acceptance rate, of course, could mean increasing the number of papers at the lower end of the quality spectrum, and perhaps up the rate of retractions.
We have a bizarre tale to relate involving the journal Surgery News, which recently lost its editor-in-chief over a rather strange editorial he wrote in the February issue of the magazine.
The ill-fated — and, we’ll stipulate, ill-advised — commentary has led to a de facto retraction of the entire publication — meaning that although no retraction notice exists that we’re aware of, neither does the issue exist in the publication’s archives.
But first, some important background. Surgery News is a trade magazine with a complicated structure. The publication, which describes itself as “the official newspaper of the American College of Surgeons [ACS],” is published by Elsevier, which supplies medical news through its International Medical News Group division. The society provides its own news, as well as the lead editor, a surgeon, who until recently was Lazar Greenfield. Greenfield, of the University of Michigan, also happens to be the president-elect of the ACS, twin responsibilities that put him at the pinnacle of influence for his specialty.